ODDB.org: Open Drug Database

NOBEL Pharma Schweiz AG - Pantoprazol NOBEL 40 mg, magensaftresistente Tabletten

Swissmedic Registration	67644	Sequence	02
Product name	Pantoprazol NOBEL 40 mg	Description	magensaftresistente Tabletten
ATC-Classification	A02BC02	ATC-Description	Pantoprazole
Introduction of Sequence	13.09.2019

Composition

pantoprazolum 40 mg ut pantoprazolum natricum sesquihydricum, trinatrii phosphas anhydricus, isomaltum 58.5 mg, carmellosum natricum, crospovidonum, natrii stearylis fumaras, Überzug: hypromellosum, povidonum K 25, propylenglycolum, E 171, E 172, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, triethylis citras, dimeticonum, sorbitani stearas, polysorbatum 60, silica colloidalis anhydrica, xanthani gummi, E 210 < 1.3 µg, E 200, kalii hydroxidum, acidum hydrochloridum, pro compresso obducto corresp. natrium 7.17 mg.

Packungsbestandteile

Galenic Form

Gastric juice resistant tablets

Active Agent	Dose
Pantoprazole	40 mg

BAG: Active Agent	Dose
Pantoprazole	40 mg

Inactive agents	Dose	additional_information
Acidi Methacrylici
Acidum Hydrochloridum
Carmellose Sodium
Crospovidonum
Dimeticone
E 171		color.
E 172		color.
E 200		conserv.
Ethylis Acrylatis Polymerisatum
Hypromellosum		Überzug
Isomaltum	58.5 mg
Kalii Hydroxidum
Natrii Stearylis Fumaras
Polysorbatum 60
Povidonum K	25
Pro Compresso Obducto
Propylenglycol
Silica Colloidalis Anhydrica
Sorbitani Stearas
Triethylis Citras
Trinatrii Phosphas Anhydricus
Xanthani Gummi

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
005	7	3.53	8.15	B	SL	Yes
006	15	6.58	15.75	B	SL	Yes
007	30	12.67	26.85	B	SL	Yes
008	60	22.03	41.75	B	SL	Yes
009	105	33.04	54.40	B	SL	Yes

2024	©ywesee GmbH